Tandem Diabetes Care Inc
(STU:TD5A)
€
17.5
+0.60 (+3.57%)
Market Cap: 1.19 Bil
Enterprise Value: 1.34 Bil
PE Ratio: 0
PB Ratio: 10.40
GF Score: 69/100 Tandem Diabetes Care Inc at Morgan Stanley Healthcare Conference Transcript
Sep 11, 2019 / 02:30PM GMT
Release Date Price:
€56.49
(+0.50%)
Marissa Elizabeth Bych
Morgan Stanley, Research Division - Research Associate
Hi, we're on the clock, so I think we can go ahead and get started.
John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director
All right.
Marissa Elizabeth Bych
Morgan Stanley, Research Division - Research Associate
Good morning, everyone. My name is Marissa Bych, I am a medical technology research associate on David Lewis' team at Morgan Stanley. And so I'm with Tandem Diabetes this morning. We have John Sheridan, the President and CEO; and we also have Leigh Vosseller, the EVP and CFO of the company with us. Very excited to have you both with us today.
Questions & Answers
Marissa Elizabeth Bych
Morgan Stanley, Research Division - Research Associate
If we could start off, what is Tandem, briefly for those who may be less familiar? And then talk to us at a high level about what has changed for your company? Over the past 1 to 2 years, you've launched a new product
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot